These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3422105)
1. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. Garg A; Grundy SM N Engl J Med; 1988 Jan; 318(2):81-6. PubMed ID: 3422105 [TBL] [Abstract][Full Text] [Related]
2. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615 [TBL] [Abstract][Full Text] [Related]
3. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. Garg A; Bonanome A; Grundy SM; Zhang ZJ; Unger RH N Engl J Med; 1988 Sep; 319(13):829-34. PubMed ID: 3045553 [TBL] [Abstract][Full Text] [Related]
4. [Lovastatin in the treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus patients]. Zanella MT; Plavinik F; Zampieri M; Peres RB; Ribeiro AB Arq Bras Cardiol; 1993 Jul; 61(1):27-31. PubMed ID: 8285861 [TBL] [Abstract][Full Text] [Related]
5. Management of primary mixed hyperlipidemia with lovastatin. Vega GL; Grundy SM Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864 [TBL] [Abstract][Full Text] [Related]
6. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus. Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046 [TBL] [Abstract][Full Text] [Related]
7. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination. Yeshurun D; Abukarshin R; Elias N; Lanir A; Naschitz JE Clin Ther; 1993; 15(2):355-63. PubMed ID: 8519043 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia. McPherson R; Bedard J; Connelly P; Curnew G; Davignon J; Echenberg D; Lavin P; Leiter L; Lenis J; McQueen M Clin Ther; 1992; 14(2):276-91. PubMed ID: 1611649 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. Hunninghake DB; Stein EA; Dujovne CA; Harris WS; Feldman EB; Miller VT; Tobert JA; Laskarzewski PM; Quiter E; Held J N Engl J Med; 1993 Apr; 328(17):1213-9. PubMed ID: 8464431 [TBL] [Abstract][Full Text] [Related]
10. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies. Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958 [TBL] [Abstract][Full Text] [Related]
11. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study]. Forti N; Ramires JA Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203 [TBL] [Abstract][Full Text] [Related]
12. Treatment of dyslipidemia in non-insulin-dependent diabetes mellitus with lovastatin. Garg A; Grundy SM Am J Cardiol; 1988 Nov; 62(15):44J-49J. PubMed ID: 3055923 [TBL] [Abstract][Full Text] [Related]
13. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus. Waysbort J; Regitz G; Brunner D Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618 [TBL] [Abstract][Full Text] [Related]
14. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus. Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874 [TBL] [Abstract][Full Text] [Related]
15. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894 [TBL] [Abstract][Full Text] [Related]
16. Effects of lovastatin in diabetic patients treated with chlorpropamide. Johnson BF; LaBelle P; Wilson J; Allan J; Zupkis RV; Ronca PD Clin Pharmacol Ther; 1990 Oct; 48(4):467-72. PubMed ID: 2225707 [TBL] [Abstract][Full Text] [Related]
17. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. Bell DS Clin Ther; 1995; 17(5):901-10. PubMed ID: 8595642 [TBL] [Abstract][Full Text] [Related]
18. Lovastatin lowers serum cholesterol levels in non-insulin-dependent diabetes mellitus patients without altering their insulin sensitivity. Hwu CM; Shih KC; Kwok CF; Chang CL; Ho LT Zhonghua Yi Xue Za Zhi (Taipei); 1996 Mar; 57(3):169-76. PubMed ID: 8935222 [TBL] [Abstract][Full Text] [Related]
19. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment. Kudolo GB; Bressler P; DeFronzo RA J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136 [TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM. Garg A; Grundy SM Diabetes; 1989 Mar; 38(3):364-72. PubMed ID: 2917701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]